'AstraZeneca ditches vaccine plant' and Trump's EU tariff threat
The Financial Times leads on AstraZeneca's decision to scrap plans for a new vaccine manufacturing plant in Liverpool, calling it "a blow to the government's growth agenda". The paper says executives have warned that policies pursued by the government will make the UK a less attractive place to invest.
AstraZeneca has abandoned a £450m investment in a major UK vaccine plant just days after Rachel Reeves vowed to “kick-start ...
The former head of the Covid Vaccine Task Force has condemned the government's 'own goal' in slashing a grant to help AstraZeneca expand in the UK. Dr Clive Dix said the company, hailed for its ...
In substance and timing, AstraZeneca's decision to cancel a planned expansion of its flu vaccine facility at Speke is a blow ...
AstraZeneca Plc abandoned plans to invest £450 million ($558 million) in a UK vaccine manufacturing plant, following protracted wrangling with the new Labour government over the level of state funding ...
Looking back, Pavord’s feelings about helping to get the AstraZeneca jab onto the market are somewhat mixed. The jab was heralded as “the vaccine for the world” on the basis that unlike the ...
Rachel Reeves was dealt yet another blow after AstraZeneca cancelled a planned £450 million investment in a vaccine manufacturing plant. The chancellor came under fire on GB News for "making an ...
All nine macaques given the control developed severe disease when exposed to bird flu, as did all given the smallest dose of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback